Abstract:A plasmid vector expressing the full-length rabies virus glycoprotein (G protein) under the control of the simian virus 40 (SV40) promoter has previously been shown to induce upon intramuscular (i.m.) inoculation into mice a specific B- and T-cell-mediated immune response and protection against challenge with a virulent strain of the virus. Here we tested two parameters that might affect the efficacy of this DNA vaccine. First, we replaced the SV40 promoter of the original vector with the early promoter derived from cytomegalovirus leaving all other parameters of the plasmid intact. Although upon transfection in vitro the two vectors showed a striking difference in their ability to cause stable expression of the rabies virus G protein, upon i.m. inoculation into mice both constructs induced comparable immune responses. Second, we constructed a vector that induces expression of a secreted form of rabies G protein by inserting a stop codon just upstream of the transmembrane domain of the rabies G protein gene. The immune responses to the DNA vaccines expressing the two different forms of the G protein, secreted and membrane bound, were compared and found to be similar in magnitude. The long-term effect of DNA vaccination was also investigated especially with regard to adverse immunological reactions such as the induction of unresponsiveness against rabies virus and the development of antibodies to DNA. DNA vaccination was found to induce long-lasting immunity to rabies virus without apparent negative side effects such as development of T cell tolerance or generation of anti-DNA antibodies.

EXPRESSION AND CHARACTERIZATION OF PHOSPHOPROTEIN OF RABIES VIRUS IN BACULOVIRUS

Cell Surface Display of Rabies Virus Glycoprotein by Using Ice Nucleation Protein

Cloning and Expression of the Nucleoprotein Gene of Era Rabies Virus

Expression of Nucleoprotein of Rabies Virus in Bac-To-Bac/AcMNPV Baculovirus Expression System

Prokaryotic Expression,Purification and Identification of Rabies Virus Glycoprotein Extracellular Domain Gene

High-level Expression of Nucleoprotein Gene of Rabies Virus in Escherichia Coli

High Level Expression of Rabies Virus Glycoprotein Extracellular Domain Gene in Escherichia Coli

Expression of E2 Protein of Classical Swine Fever Virus Shimen Strain Using Baculovrius Expression System

Novel Strategy for Expression and Characterization of Rabies Virus Glycoprotein

Prokaryoticexpression and Immunoreactivity Analysis of Rabies G Protein

Study on Expression and Immunogenicity of Rabies Virus Nucleoprotein

Expression of the Receptor-Binding Region of SARS-CoV Spike Protein in Baculovirus Vector and Identifying Its Antigenicity

Immunogenicity and Antigenicity of the Ectodomain of Rabies Virus Glycoprotein Stably Expressed in HEK293T Cells

Prokaryotic Expression of GP5 of PRRSV and Analysis of Its Immunoreactivity

[Expression and purification of rabies virus glycoprotein and analysis of its specific binding capacity to memory B cells]

Expression and purification of classical swine fever virus E2 protein from Sf9 cells using a modified vector

Expression of variable viruses as herpes simplex glycoprotein D and varicella zoster gE glycoprotein using a novel plasmid based expression system in insect cell

Proteomic Profiling of Purified Rabies Virus Particles.

Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system

Fusion Expression of Structural Proteins of Porcine Reproductive and Respiratory Syndrome Virus.

Immune Responses to Nucleic Acid Vaccines to Rabies Virus